These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1886444)

  • 1. Quantifying the spread of botulinum toxin through muscle fascia.
    Shaari CM; George E; Wu BL; Biller HF; Sanders I
    Laryngoscope; 1991 Sep; 101(9):960-4. PubMed ID: 1886444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
    Shaari CM; Sanders I
    Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.
    Borodic GE; Ferrante R; Pearce LB; Smith K
    Mov Disord; 1994 Jan; 9(1):31-9. PubMed ID: 8139603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle.
    George EF; Zimbler M; Wu BL; Biller HF; Sanders I
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):888-92. PubMed ID: 1444095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin injections as a method for chemically denervating skeletal muscle to test functional hypotheses: a pilot study in Lepomis cyanellus.
    O'Neill MW; Gibb AC
    Physiol Biochem Zool; 2007; 80(2):241-9. PubMed ID: 17252520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of botulinum toxin A on functional outcome during distraction osteogenesis.
    Olabisi R; Best TM; Vanderby R; Petr S; Noonan KJ
    J Orthop Res; 2007 May; 25(5):656-64. PubMed ID: 17262822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of superfluous neuromuscular junctions in rat calf muscles recovering from botulinum toxin-induced paralysis.
    Hassan SM; Jennekens FG; Wieneke G; Veldman H
    Muscle Nerve; 1994 Jun; 17(6):623-31. PubMed ID: 8196705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional study of four neurotoxins as inhibitors of post-traumatic nerve regeneration.
    Paydarfar JA; Paniello RC
    Laryngoscope; 2001 May; 111(5):844-50. PubMed ID: 11359163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Botox and Neuronox on muscle force generation in mice.
    Stone AV; Ma J; Whitlock PW; Koman LA; Smith TL; Smith BP; Callahan MF
    J Orthop Res; 2007 Dec; 25(12):1658-64. PubMed ID: 17600825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pupillary effects of retrobulbar injection of botulinum toxin A (oculinum) in albino rats.
    Levy Y; Kremer I; Shavit S; Korczyn AD
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):122-5. PubMed ID: 1987093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread.
    Borodic GE; Joseph M; Fay L; Cozzolino D; Ferrante RJ
    Head Neck; 1990; 12(5):392-9. PubMed ID: 2211099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of botulinum toxin A on muscle histology during distraction osteogenesis.
    Olabisi R; Chamberlain CS; Petr S; Steiner S; Consigny D; Best TM; Vanderby R; Schultz E; Noonan KJ
    J Orthop Res; 2009 Mar; 27(3):310-7. PubMed ID: 18752291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
    Lim EC; Seet RC
    Acta Neurol Scand; 2008 Feb; 117(2):73-84. PubMed ID: 17850405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous output of acetylcholine from rat diaphragm preparations declines after treatment with botulinum toxin.
    Gundersen CB; Jenden DJ
    J Pharmacol Exp Ther; 1983 Feb; 224(2):265-8. PubMed ID: 6822953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: an experimental study.
    Cakmak M; Caglayan F; Somuncu S; Leventoglu A; Ulusoy S; Akman H; Kaya M
    J Pediatr Surg; 2006 Apr; 41(4):821-5. PubMed ID: 16567201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of diffusion and duration of action of a new botulinum toxin type A formulation.
    Stone HF; Zhu Z; Thach TQ; Ruegg CL
    Toxicon; 2011 Aug; 58(2):159-67. PubMed ID: 21658400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neuromuscular blockade and recovery with botulinum toxins A and F.
    Billante CR; Zealear DL; Billante M; Reyes JH; Sant'Anna G; Rodriguez R; Stone RE
    Muscle Nerve; 2002 Sep; 26(3):395-403. PubMed ID: 12210370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study.
    Bertolasi L; Priori A; Tomelleri G; Bongiovanni LG; Fincati E; Simonati A; De Grandis D; Rizzuto N
    Ann Neurol; 1997 Feb; 41(2):181-6. PubMed ID: 9029067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.